Literature DB >> 12789269

Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.

Richard A Steinman1, Abbey Wentzel, Yalin Lu, Christine Stehle, Jennifer Rubin Grandis.   

Abstract

The signal transducing protein Stat3 activates gene transcription in cells in response to multiple cytokines. Constitutive activation of Stat3 has been observed in solid tumors including head and neck squamous cell carcinoma. Stat3 activation in cancer has been associated with autocrine stimulatory loops and is believed to convey a growth advantage to cells. We now demonstrate ligand-independent activation of Stat3 by high cell density in multiple cancer cell lines. Activation of Stat3 is associated with antiproliferative rather than proliferative conditions. Interference with cdk2 activity upregulates Stat3 phosphorylation and Stat3-directed DNA-binding activity. Our data supports a model in which Stat3 activity is partially suppressed by cdk2 in growing cells and derepressed upon cell confluence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789269     DOI: 10.1038/sj.onc.1206523

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

Review 1.  Systematic review of factors influencing extracellular vesicle yield from cell cultures.

Authors:  Johann Mar Gudbergsson; Kasper Bendix Johnsen; Martin Najbjerg Skov; Meg Duroux
Journal:  Cytotechnology       Date:  2015-10-03       Impact factor: 2.058

2.  PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Authors:  Ester Bonastre; Sara Verdura; Ilse Zondervan; Federica Facchinetti; Sylvie Lantuejoul; Maria Dolores Chiara; Juan Pablo Rodrigo; Julian Carretero; Enric Condom; Agustin Vidal; David Sidransky; Alberto Villanueva; Luca Roz; Elisabeth Brambilla; Suvi Savola; Montse Sanchez-Cespedes
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

Review 3.  The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Authors:  Leda Raptis; Rozanne Arulanandam; Mulu Geletu; James Turkson
Journal:  Exp Cell Res       Date:  2011-05-18       Impact factor: 3.905

4.  Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.

Authors:  Yi-Pei Lin; Jun-I Wu; Chien-Wei Tseng; Huei-Jane Chen; Lu-Hai Wang
Journal:  Oncogene       Date:  2018-09-03       Impact factor: 9.867

5.  STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells.

Authors:  Akiko Onishi; Qianming Chen; Joseph O Humtsoe; Randall H Kramer
Journal:  Exp Cell Res       Date:  2007-09-29       Impact factor: 3.905

6.  Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.

Authors:  Julia Dambacher; Florian Beigel; Julia Seiderer; Dirk Haller; Burkhard Göke; Christoph J Auernhammer; Stephan Brand
Journal:  Gut       Date:  2007-04-20       Impact factor: 23.059

7.  Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.

Authors:  Hsiao-Wen Su; Shainn-Wei Wang; Fayez K Ghishan; Pawel R Kiela; Ming-Jer Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-22       Impact factor: 4.249

8.  Notch signaling regulates cell density-dependent apoptosis of NIH 3T3 through an IL-6/STAT3 dependent mechanism.

Authors:  Yosuke Matsuno; Takumi Kiwamoto; Yuko Morishima; Yukio Ishii; Nobuyuki Hizawa; Cory M Hogaboam
Journal:  Eur J Cell Biol       Date:  2018-09-12       Impact factor: 4.492

9.  Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.

Authors:  Nicole L Moore; Dean P Edwards; Nancy L Weigel
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-16       Impact factor: 4.292

10.  ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB.

Authors:  Yuqing Zhang; Uddalak Bharadwaj; Craig D Logsdon; Changyi Chen; Qizhi Yao; Min Li
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.